Works by Kesselheim, Aaron S.
Results: 478
Medicare Spending on Drugs With Accelerated Approval, 2015-2019.
- Published in:
- JAMA Health Forum, 2021, v. 2, n. 12, p. 1, doi. 10.1001/jamahealthforum.2021.3937
- By:
- Publication type:
- Article
Estimating Rebates and Other Discounts Received by Medicare Part D.
- Published in:
- JAMA Health Forum, 2021, v. 2, n. 6, p. 1, doi. 10.1001/jamahealthforum.2021.0626
- By:
- Publication type:
- Article
Association between changes in prices and out‐of‐pocket costs for brand‐name clinician‐administered drugs.
- Published in:
- Health Services Research, 2024, v. 59, n. 6, p. 1, doi. 10.1111/1475-6773.14279
- By:
- Publication type:
- Article
Market dynamics of authorized generics in Medicaid from 2014 to 2020.
- Published in:
- Health Services Research, 2023, v. 58, n. 4, p. 953, doi. 10.1111/1475-6773.14145
- By:
- Publication type:
- Article
Alternatives to the quality‐adjusted life year: How well do they address common criticisms?
- Published in:
- Health Services Research, 2023, v. 58, n. 2, p. 433, doi. 10.1111/1475-6773.14116
- By:
- Publication type:
- Article
Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022.
- Published in:
- Journal of Health Politics, Policy & Law, 2024, v. 49, n. 2, p. 249, doi. 10.1215/03616878-10989695
- By:
- Publication type:
- Article
Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process.
- Published in:
- Journal of Health Politics, Policy & Law, 2023, v. 48, n. 5, p. 799, doi. 10.1215/03616878-10637726
- By:
- Publication type:
- Article
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 6, p. 879, doi. 10.1215/03616878-10041247
- By:
- Publication type:
- Article
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature Review.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 6, p. 649, doi. 10.1215/03616878-10041093
- By:
- Publication type:
- Article
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases.
- Published in:
- Journal of Health Politics, Policy & Law, 2021, v. 46, n. 3, p. 487, doi. 10.1215/03616878-8893571
- By:
- Publication type:
- Article
Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1131, doi. 10.1007/s40273-022-01195-x
- By:
- Publication type:
- Article
Eliminating Coverage Discrimination Through the Essential Health Benefit's Anti-Discrimination Provisions.
- Published in:
- American Journal of Public Health, 2017, v. 107, n. 2, p. 253, doi. 10.2105/AJPH.2016.303563
- By:
- Publication type:
- Article
Prescription Drug Insurance Coverage and Patient Health Outcomes: A Systematic Review.
- Published in:
- American Journal of Public Health, 2015, v. 105, n. 2, p. e17, doi. 10.2105/AJPH.2014.302240
- By:
- Publication type:
- Article
Cost-effectiveness of Statin Therapy for ASCVD.
- Published in:
- 2015
- By:
- Publication type:
- commentary
Experience With the Priority Review Voucher Program for Drug Development.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Safety of Prescription Drugs.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Electronic medication packaging devices and medication adherence: a systematic review.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Electronic Medication Packaging Devices and Medication Adherence.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 12, p. 1237, doi. 10.1001/jama.2014.10059
- By:
- Publication type:
- Article
What Is the Public's Right to Access Medical Discoveries Based on Federally Funded Research?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Underrepresentation of Older Adults in Cancer Trials.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
FDA Approval of Cardiac Implantable Electronic Devices via Original and Supplement Premarket Approval Pathways, 1979-2012.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 4, p. 385, doi. 10.1001/jama.2013.284986
- By:
- Publication type:
- Article
Who Is Now Responsible for Discovering and Warning About Adverse Effects of Generic Drugs?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Balancing access and innovation: India's Supreme Court rules on imatinib.
- Published in:
- 2013
- By:
- Publication type:
- journal article
India's Supreme Court Rules on Imatinib.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
FDA Regulation of Off-label Drug Promotion Under Attack.
- Published in:
- 2013
- By:
- Publication type:
- Interview
Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 10, p. 973, doi. 10.1001/2012.jama.10647
- By:
- Publication type:
- Article
Clinical Trials of Orphan Drugs for Cancer.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Conflict of Interest Disclosure in Early Education of Medical Students.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 22, p. 2320, doi. 10.1001/jama.2011.769
- By:
- Publication type:
- Article
Medicare Negotiation's Drug Reformulation Problem.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 6, p. 833, doi. 10.7326/M23-3212
- By:
- Publication type:
- Article
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 1, p. 1, doi. 10.7326/L23-0429
- By:
- Publication type:
- Article
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022: An Interrupted Time-Series Analysis.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 11, p. 1508, doi. 10.7326/M23-1609
- By:
- Publication type:
- Article
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 10, p. 1413, doi. 10.7326/M23-0623
- By:
- Publication type:
- Article
The Regulatory Repercussions of Approving Muscular Dystrophy Medications on the Basis of Limited Evidence.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 9, p. 1251, doi. 10.7326/M23-1073
- By:
- Publication type:
- Article
Moving Naloxone Over the Counter Is Necessary but Not Sufficient.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 8, p. 1109, doi. 10.7326/M23-0852
- By:
- Publication type:
- Article
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 8, p. 1047, doi. 10.7326/M23-0615
- By:
- Publication type:
- Article
Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.
- Published in:
- 2022
- By:
- Publication type:
- research
Direct-to-Consumer Generic Drugs: A Maverick Approach or Another Exposure of Market Failures?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Revisiting the National Institutes of Health Fair Pricing Condition: Promoting the Affordability of Drugs Developed With Government Support.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Changes in Drug Pricing After Drug Shortages in the United States.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Changes in Drug Pricing After Drug Shortages in the United States.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?".
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 9, p. 2874, doi. 10.1111/jgs.19015
- By:
- Publication type:
- Article
Patterns and Predictors of Generic Narrow Therapeutic Index Drug Use Among Older Adults.
- Published in:
- Journal of the American Geriatrics Society, 2013, v. 61, n. 9, p. 1586, doi. 10.1111/jgs.12399
- By:
- Publication type:
- Article
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Commercial markups on pediatric oncology drugs at 340B pediatric hospitals.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31158
- By:
- Publication type:
- Article
USING ANTITRUST LAW TO CHALLENGE TURING'S DARAPRIM PRICE INCREASE.
- Published in:
- Berkeley Technology Law Journal, 2017, v. 31, n. 2, p. 1379, doi. 10.15779/Z383R0PS73
- By:
- Publication type:
- Article